✦ LIBER ✦

Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia

✍ Scribed by Gianluca Miglio; Federica Varsaldi; Elisabetta Francioli; Angelo Battaglia; Pier Luigi Canonico; Grazia Lombardi

Book ID: 113584632
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 329 KB
Volume: 489
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2004.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comprehensive cytogenomic profile of the

Comprehensive cytogenomic profile of the in vitro neuronal model SH-SY5Y

✍ Mohammed Yusuf,Kay Leung,Keith J. Morris,Emanuela V. Volpi 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 356 KB

Protective effect of isoflavones against

Protective effect of isoflavones against homocysteine-mediated neuronal degeneration in SH-SY5Y cells

✍ Youn-Jin Park; Yumi Jang; Young Hye Kwon 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 579 KB

Comparison between proliferative and neu

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies

✍ Fernanda Martins Lopes; Rafael Schröder; Mário Luiz Conte da Frota Júnior; Alfeu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 910 KB

In vitro neurodegeneration model: dopami

In vitro neurodegeneration model: dopaminergic toxin-induced apoptosis in human SH-SY5Y cells

✍ Kumi Nakamura; Yoshihisa Kitamura; Daiju Tsuchiya; Masatoshi Inden; Takashi Tani 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Protective effects of quercetin against

Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells

✍ Namiko Suematsu; Miki Hosoda; Ko Fujimori 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 590 KB

D-β-hydroxybutyrate protects dopaminergi

D-β-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease

✍ Keiko Imamura; Takao Takeshima; Yoshihiro Kashiwaya; Kazuhiro Nakaso; Kenji Naka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

## Abstract It has been postulated that the pathogenesis of Parkinson's disease (PD) is associated with mitochondrial dysfunction. Rotenone, an inhibitor of mitochondrial complex I, provides models of PD both in vivo and in vitro. We investigated the neuroprotective effect of D‐β‐hydroxybutyrate (b